Latest collections open to submissions
Artificial intelligence in Rheumatology
Guest Edited by George Boateng and Angie Botto-van Bemden
Diagnosis and treatment of rheumatoid arthritis
Guest Edited by Michael Doumen
Advances in the treatment of systemic lupus erythematosus
Guest Edited by Ioannis Parodis, Chang-Hee Suh, Fangfang Sun and Jiuliang Zhao
The role of diet and lifestyle modifications in the management of rheumatic diseases
Guest Edited by Brian Andonian and Norelee Kennedy
Journal news
We are pleased to announce that BMC Rheumatology has been accepted for indexing in Clarivate's Emerging Sources Citation Index™ (ESCI). Journal content is available to view in Web of Science's indexing database. A list of all sources where BMC Rheumatology is indexed can be found here, which includes PubMed Central and Scopus.
Editor's article highlights
**patient perspectives
Articles
-
-
Protocol for the development of a tool to map systemic sclerosis pain sources, patterns, and management experiences: a Scleroderma Patient-centered Intervention Network patient-researcher partnership
-
Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study
-
Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis
-
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
-
The utility of ESR, CRP and platelets in the diagnosis of GCA
-
Diagnosis of Behçet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses
-
In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)
-
Methotrexate therapy impacts on red cell distribution width and its predictive value for cardiovascular events in patients with rheumatoid arthritis
-
A systematic review of guidelines for managing rheumatoid arthritis
Aims and scope
BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.
BMC supports:
The UN Sustainable Development Goals
Assisting policy-makers, governments and humanitarian organizations in making research-backed decisions to advance the international well-being agenda.
Supporting equity in academic publishing
For authors based in low- and middle-income countries who might face challenges in publishing their work. Follow us for guidance on submitting your research to us.
We are recruiting new Editorial Board Members
We are recruiting new Editorial Board Members to join our international community of experts, helping to provide expertise on a wide range of subjects within the area of rheumatology.
Read MoreBMC Series blog
-
-
-
Highlights of the BMC Series – May 2024
19 June 2024
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.1
5-year Journal Impact Factor: 2.5
Source Normalized Impact per Paper (SNIP): 0.776
SCImago Journal Rank (SJR): 0.805
Speed 2023
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 247
Usage 2023
Downloads: 398,220
Altmetric mentions: 294
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication